Philippe Glorieux

First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.

Peter Hantos, Thomas C. Chen, Thomas C Chen, 2015, Vaccine.